KRAS-G12C covalent inhibitors: A game changer in the scene of cancer therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KRAS-G12C covalent inhibitors: A game changer in the scene of cancer therapies

Published:2021-12 Issue: Volume:168 Page:103524
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Naim Nabih^ORCID,Moukheiber Sara^ORCID,Daou Samah^ORCID,Kourie Hampig Raphael

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference98 articles.

1. Epithelial-to-Mesenchymal transition is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C–Mutant non–Small cell lung Cancer;Adachi;Clin. Cancer Res.,2020

2. Posttranslational modifications of RAS proteins;Ahearn;Cold Spring Harb. Perspect. Med.,2018

3. EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal Cancer;Amodio;Cancer Discov.,2020

4. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015

5. Acquired resistance to KRASG12C inhibition in Cancer;Awad;N. Engl. J. Med.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

2. RAS degraders: The new frontier for RAS-driven cancers;Molecular Therapy;2023-07

3. KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer;Mini-Reviews in Medicinal Chemistry;2023-05

4. Experimental study on the suppressive effect of B3GNT3 on the apoptosis of lung adenocarcinoma cells and its application in early screening for lung adenocarcinoma;Journal of Thoracic Disease;2023-03

5. Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer;Current Medicinal Chemistry;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3